MonTa Biosciences
Pre-clinicalMonTa Biosciences develops novel immunotherapies targeting cancer and autoimmune diseases using advanced antibody engineering platforms.
Founded
2019
Focus
Small Molecules
About
MonTa Biosciences develops novel immunotherapies targeting cancer and autoimmune diseases using advanced antibody engineering platforms.
Funding History
1Total raised: $2.5M
Seed$2.5MNovo SeedsJun 15, 2022
Company Info
TypePrivate
Founded2019
LocationCopenhagen, Denmark
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
MipSalus
Pre-clinical · Copenhagen
FluoGuide
Pre-clinical · Copenhagen
Fuse Vectors
Pre-clinical · Copenhagen
Fida Biosystems
Pre-clinical · Copenhagen
CerCell
Pre-clinical · Copenhagen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile